O Berk pharma bottle is ready to ship

Published: 27-May-2010

HDPE Pharma Oblong in amber now available from stock

O Berk pharma bottle is ready to ship
O Berk Company, a US supplier and distributor of glass and plastic containers, closures, pumps and sprayers for the pharmaceutical and healthcare industries, is offering its 16oz HDPE Pharma Oblong bottle in amber from stock. The bottle is also available by special order in natural, white or a custom colour.

The 16oz Pharma Oblong is suitable for prescription and over-the-counter (OTC) liquid pharmaceutical products. There bottle is supplied with a variety of child-resistant and standard continuous threaded closures. The bottle surface has an indented panel that is easy to personalise.

Both bottles and closures are supported with data indicating US FDA compliance.

See more

You may also like

Media
Siemens named Leader in IDC MarketScape assessment of life sciences R&D technology

Siemens named Leader in IDC MarketScape assessment of life sciences R&D technology

Read more
The company has been recognised for its end-to-end digital capabilities, AI-enabled portfolio and open Smart Lab Ecosystem in IDC’s 2026 assessment of life sciences R&D technology providers, with case studies from GSK and AstraZeneca highlighting the potential of digital twins and process modelling to accelerate development and manufacturing

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
  2. Merck KGaA divests US CDMO business to Lonza Merck KGaA will sell its US CDMO business to Lonza in a deal worth hundreds of millions of Swiss francs, expanding Lonza's US manufacturing footprint and marking a strategic shift for Merck
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    UK Budget 2026: what it means for pharma manufacturing VAT relief on free medicines, £1bn in new investment and revised capital allowances give pharma manufacturers progress — but gaps remain
  4. Pharma’s silent sustainability risk and the supply chain fix Pharma is making efforts to cut emissions from its own operations: shifting to renewables, upgrading facilities, streamlining logistics²⁰. But a significant share of emissions still hides outside the company’s direct control – yet in plain sight. Now, regulators and investors are turning their focus beyond the factory gates, deep into the value chain. What they’re finding is already reshaping the rules of competitiveness, capital access, and compliance. One of pharma’s most overlooked risks is quietly moving into the foreground. And the time to act is narrowing
  5. Panthera expands Glasgow clinical research capacity with new centre at Health Innovation Hub Purpose-built facility will support Phase II and III trials and broaden participation across Glasgow and the west of Scotland

You may also like

Media
Siemens named Leader in IDC MarketScape assessment of life sciences R&D technology

Siemens named Leader in IDC MarketScape assessment of life sciences R&D technology

The company has been recognised for its end-to-end digital capabilities, AI-enabled portfolio and open Smart Lab Ecosystem in IDC’s 2026 assessment of life sciences R&D technology providers, with case studies from GSK and AstraZeneca highlighting the potential of digital twins and process modelling to accelerate development and manufacturing
Finance
Viral vector CDMO VintaBio’s Philadelphia facility and IP up for sale

Viral vector CDMO VintaBio’s Philadelphia facility and IP up for sale

VintaBio’s assignee is seeking bids for its cGMP facility, equipment and proprietary AAV technology as gene therapy contract manufacturers face overcapacity
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing

How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing

Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance processes and maintain reliable output across demanding production lines
Ingredients
UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny

UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny

The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical manufacturers face growing pressure around the use of forever chemicals
Manufacturing
Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India

Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India

The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at its Raichur campus, expanding its capabilities to meet demand for GLP-1s and increasingly complex peptide therapeutics across oncology and rare diseases
Pharmaceutical
OGT launches four IVDR-certified CytoCell FISH probes for haematological malignancy diagnostics

OGT launches four IVDR-certified CytoCell FISH probes for haematological malignancy diagnostics

The new probes advance OGT’s transition of its CytoCell portfolio from IVDD ahead of the December 2028 Class C deadline, helping laboratories maintain compliant leukaemia and myeloma testing workflows
Finance
Merck KGaA divests US CDMO business to Lonza

Merck KGaA divests US CDMO business to Lonza

Merck KGaA will sell its US CDMO business to Lonza in a deal worth hundreds of millions of Swiss francs, expanding Lonza's US manufacturing footprint and marking a strategic shift for Merck
Subscribe now